Active Ingredient
Salicylic Acid 17%
The following Structured Product Label (SPL) was submitted to the FDA by Clinical Therapeutic Solutions for the product Verrustat Wart Remover (NDC 44577-020). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses:, warnings, directions, other information, other ingredients, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Salicylic Acid 17%
wart treatment
For external use only. Do not use this product on irritated skin, on any area that is infected or reddened, if you are a diabetic, or if you have poor blood circulation. If discomfort persists, see your doctor. Do not use on moles, birthmarks, warts with hair growing from them, genital warts, or warts on the face or mucous membranes. Flammable. Keep away from fire or flame. Cap bottle tightly and store at room temperature away from heat. If product gets into the eye, flush with water for 15 minutes. Avoid inhaling vapors.
Butyl Acetate, Ethyl Acetate, Isopropyl Alcohol, Methylsulfonylmethane (MSM), Nitrocellulose, Retinyl Palmitate, SD-Alcohol 40B
* Please review the disclaimer below.